These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Accuracy of Repetitive Ocular Vestibular-Evoked Myogenic Potentials to Diagnose Myasthenia Gravis in Patients With Ptosis or Diplopia. Valko Y; Wirth MA; Fierz FC; Schesny MK; Rosengren S; Schmückle-Meier T; Bockisch CJ; Straumann D; Schreiner B; Weber KP Neurology; 2024 May; 102(10):e209395. PubMed ID: 38669629 [TBL] [Abstract][Full Text] [Related]
9. Eye muscle antibodies in patients with ocular myasthenia gravis: possible mechanism for eye muscle inflammation in acetylcholine-receptor antibody-negative patients. Gunji K; Skolnick C; Bednarczuk T; Benes S; Ackrell BA; Cochran B; Kennerdell JS; Wall JR Clin Immunol Immunopathol; 1998 Jun; 87(3):276-81. PubMed ID: 9646837 [TBL] [Abstract][Full Text] [Related]
10. [Ocular myasthenia gravis: diagnostic aspects and evolution]. de Entrambasaguas M; López-Bernabé R; López-Alemany M Rev Neurol; 2007 Apr 1-15; 44(7):397-403. PubMed ID: 17420965 [TBL] [Abstract][Full Text] [Related]
11. Risk Factors for Generalization in Patients with Ocular Myasthenia Gravis: A Multicenter Retrospective Cohort Study. Guo RJ; Gao T; Ruan Z; Zhou HY; Gao F; Xu Q; Yu LP; Wu SD; Lei T; Li HH; Sun C; Zhang M; Gao YW; Lu XD; Tang YL; Tang BL; Huo FY; Zhu Y; Li ZY; Chang T Neurol Ther; 2022 Mar; 11(1):73-86. PubMed ID: 34729706 [TBL] [Abstract][Full Text] [Related]
12. Acetylcholine receptor antibody positivity rate in ocular myasthenia gravis: a matter of age? Monte G; Spagni G; Damato V; Iorio R; Marino M; Evoli A J Neurol; 2021 May; 268(5):1803-1807. PubMed ID: 33387011 [TBL] [Abstract][Full Text] [Related]
13. Ocular Myasthenia: Clinical Course and the Diagnostic Utility of Assaying Acetylcholine Receptor Antibodies. Behbehani R; Ali A; Al-Moosa A Neuroophthalmology; 2022; 46(4):220-226. PubMed ID: 35859633 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy and clinical utility of bed side tests versus laboratory tests in the diagnosis of ocular myasthenia. Sivakumar P; Tagare S; Kumar M Indian J Ophthalmol; 2022 Apr; 70(4):1331-1337. PubMed ID: 35326049 [TBL] [Abstract][Full Text] [Related]
15. Prediction of generalization of ocular myasthenia gravis under immunosuppressive therapy in Northwest China. Ding J; Zhao S; Ren K; Dang D; Li H; Wu F; Zhang M; Li Z; Guo J BMC Neurol; 2020 Jun; 20(1):238. PubMed ID: 32527235 [TBL] [Abstract][Full Text] [Related]
16. Single-fiber Electromyography in the Extensor Digitorum Communis for the Predictive Prognosis of Ocular Myasthenia Gravis: A Retrospective Study of 102 Cases. Guan YZ; Cui LY; Liu MS; Niu JW Chin Med J (Engl); 2015 Oct; 128(20):2783-6. PubMed ID: 26481746 [TBL] [Abstract][Full Text] [Related]
17. Development of generalized disease at 2 years in patients with ocular myasthenia gravis. Kupersmith MJ; Latkany R; Homel P Arch Neurol; 2003 Feb; 60(2):243-8. PubMed ID: 12580710 [TBL] [Abstract][Full Text] [Related]
18. Presence and pathogenic relevance of antibodies to clustered acetylcholine receptor in ocular and generalized myasthenia gravis. Jacob S; Viegas S; Leite MI; Webster R; Cossins J; Kennett R; Hilton-Jones D; Morgan BP; Vincent A Arch Neurol; 2012 Aug; 69(8):994-1001. PubMed ID: 22689047 [TBL] [Abstract][Full Text] [Related]
19. Prognosis of Ocular Myasthenia Gravis in an Argentinian Population. Aguirre F; Villa AM Eur Neurol; 2018; 79(3-4):113-117. PubMed ID: 29428956 [TBL] [Abstract][Full Text] [Related]
20. Risk for generalization in ocular onset myasthenia gravis: experience from a neuro-ophthalmology clinic. Kısabay A; Özdemir HN; Gökçay F; Çelebisoy N Acta Neurol Belg; 2022 Apr; 122(2):337-344. PubMed ID: 33544334 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]